IDH1 and central nervous system cancer: For instance, IDH mutations are a favorable prognostic indicator for glioma patients, and neutrophil infiltration is less common in IDH-mutated gliomas compared to wild-type GBMs due to suppression of genes linked to chemotaxis and lack of immunosuppressive effects (131–133).